{'text': 'Imbruvica (Ibrutinib) for the Treatment of Mantle Cell Lymphoma (MCL)', 'publisher': {'href': 'https://www.clinicaltrialsarena.com', 'title': 'Clinical Trials Arena'}, 'created_at': 'Thu, 29 Jan 2015 08:00:00 GMT', 'description': 'Imbruvica (Ibrutinib) for the Treatment of Mantle Cell Lymphoma (MCL)  Clinical Trials Arena', 'url': 'https://news.google.com/rss/articles/CBMiswFBVV95cUxNYW5wTUIxWGxOV25ZaEdWdnJaM2F4blJwdWFFQ1dPcXRfb3d5aC1ROUl5WlVwRjlpbkdqUE9TaGcxMl81RlQ4bUExVFM0ZDlhSnFWRTR4U09jd0Y0Ry1lUy14alJZV0xnQ0FfTmlYMWwyQ2FOZmd2VU5Lb3FsbVZzVUJTbnFCZndlZzA1ZVRPb2IxQWE5QUFJQ3JqV19CUDhEbFhkVS0yd1BZSlZPbE5fMmpHUQ?oc=5&hl=en-US&gl=US&ceid=US:en'}
